287 related articles for article (PubMed ID: 23091005)
21. Expanding into new markets--VCP/p97 in endocytosis and autophagy.
Bug M; Meyer H
J Struct Biol; 2012 Aug; 179(2):78-82. PubMed ID: 22450227
[TBL] [Abstract][Full Text] [Related]
22. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system.
Meyer H; Bug M; Bremer S
Nat Cell Biol; 2012 Feb; 14(2):117-23. PubMed ID: 22298039
[TBL] [Abstract][Full Text] [Related]
23. The immunoexpression of valosin-containing protein and small VCP-interacting protein in rat ovaries.
Kartal B; Alimoğulları E; Çaylı S
Anat Histol Embryol; 2023 Jul; 52(4):546-551. PubMed ID: 36843060
[TBL] [Abstract][Full Text] [Related]
24. Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha.
Dai RM; Chen E; Longo DL; Gorbea CM; Li CC
J Biol Chem; 1998 Feb; 273(6):3562-73. PubMed ID: 9452483
[TBL] [Abstract][Full Text] [Related]
25. The VCP/p97 and YOD1 Proteins Have Different Substrate-dependent Activities in Endoplasmic Reticulum-associated Degradation (ERAD).
Sasset L; Petris G; Cesaratto F; Burrone OR
J Biol Chem; 2015 Nov; 290(47):28175-28188. PubMed ID: 26463207
[TBL] [Abstract][Full Text] [Related]
26. Valosin-containing protein (VCP/p97) is required for poliovirus replication and is involved in cellular protein secretion pathway in poliovirus infection.
Arita M; Wakita T; Shimizu H
J Virol; 2012 May; 86(10):5541-53. PubMed ID: 22379090
[TBL] [Abstract][Full Text] [Related]
27. Valosin containing protein (VCP/p97) is a novel substrate for the protein tyrosine phosphatase PTPL1.
Abaan OD; Hendriks W; Uren A; Toretsky JA; Erkizan HV
Exp Cell Res; 2013 Jan; 319(1):1-11. PubMed ID: 23018179
[TBL] [Abstract][Full Text] [Related]
28. AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential.
Vij N
J Cell Mol Med; 2008 Dec; 12(6A):2511-8. PubMed ID: 18798739
[TBL] [Abstract][Full Text] [Related]
29. Hexamerization of p97-VCP is promoted by ATP binding to the D1 domain and required for ATPase and biological activities.
Wang Q; Song C; Li CC
Biochem Biophys Res Commun; 2003 Jan; 300(2):253-60. PubMed ID: 12504076
[TBL] [Abstract][Full Text] [Related]
30. Identification of SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degradation.
Ballar P; Zhong Y; Nagahama M; Tagaya M; Shen Y; Fang S
J Biol Chem; 2007 Nov; 282(47):33908-14. PubMed ID: 17872946
[TBL] [Abstract][Full Text] [Related]
31. ATPase activity of p97/valosin-containing protein is regulated by oxidative modification of the evolutionally conserved cysteine 522 residue in Walker A motif.
Noguchi M; Takata T; Kimura Y; Manno A; Murakami K; Koike M; Ohizumi H; Hori S; Kakizuka A
J Biol Chem; 2005 Dec; 280(50):41332-41. PubMed ID: 16234241
[TBL] [Abstract][Full Text] [Related]
32. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD.
Tresse E; Salomons FA; Vesa J; Bott LC; Kimonis V; Yao TP; Dantuma NP; Taylor JP
Autophagy; 2010 Feb; 6(2):217-27. PubMed ID: 20104022
[TBL] [Abstract][Full Text] [Related]
33. Valosin-containing protein (VCP/p97) is an activator of wild-type ataxin-3.
Laço MN; Cortes L; Travis SM; Paulson HL; Rego AC
PLoS One; 2012; 7(9):e43563. PubMed ID: 22970133
[TBL] [Abstract][Full Text] [Related]
34. Pathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response.
Wang T; Xu W; Qin M; Yang Y; Bao P; Shen F; Zhang Z; Xu J
J Biol Chem; 2016 Jul; 291(27):14373-14384. PubMed ID: 27226613
[TBL] [Abstract][Full Text] [Related]
35. Selenoprotein S-dependent Selenoprotein K Binding to p97(VCP) Protein Is Essential for Endoplasmic Reticulum-associated Degradation.
Lee JH; Park KJ; Jang JK; Jeon YH; Ko KY; Kwon JH; Lee SR; Kim IY
J Biol Chem; 2015 Dec; 290(50):29941-52. PubMed ID: 26504085
[TBL] [Abstract][Full Text] [Related]
36. D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP.
Wang Q; Song C; Yang X; Li CC
J Biol Chem; 2003 Aug; 278(35):32784-93. PubMed ID: 12807884
[TBL] [Abstract][Full Text] [Related]
37. VCP/p97 AAA-ATPase does not interact with the endogenous wild-type cystic fibrosis transmembrane conductance regulator.
Goldstein RF; Niraj A; Sanderson TP; Wilson LS; Rab A; Kim H; Bebok Z; Collawn JF
Am J Respir Cell Mol Biol; 2007 Jun; 36(6):706-14. PubMed ID: 17272822
[TBL] [Abstract][Full Text] [Related]
38. Molecular Mechanisms Driving and Regulating the AAA+ ATPase VCP/p97, an Important Therapeutic Target for Treating Cancer, Neurological and Infectious Diseases.
Valimehr S; Sethi A; Shukla M; Bhattacharyya S; Kazemi M; Rouiller I
Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238606
[TBL] [Abstract][Full Text] [Related]
39. Essential function of VCP/p97 in infection cycle of the nucleopolyhedrovirus AcMNPV in Spodoptera frugiperda Sf9 cells.
Lyupina YV; Erokhov PA; Kravchuk OI; Finoshin AD; Abaturova SB; Orlova OV; Beljelarskaya SN; Kostyuchenko MV; Mikhailov VS
Virus Res; 2018 Jul; 253():68-76. PubMed ID: 29890203
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the aggregation-prevention activity of p97/valosin-containing protein.
Song C; Wang Q; Li CC
Biochemistry; 2007 Dec; 46(51):14889-98. PubMed ID: 18044963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
